Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal 
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality 
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains 
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock 
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran 
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election 
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks 
Rising levels of obesity are set to cost the world economy 3.3 percent of GDP by 2060, slowing development in lower-income countries, according to a study published in BMJ Global Health.
The conditions currently cost 2.2 percent of global GDP, and the biggest increases are expected in lower-resourced countries.
In terms of absolute costs, China, the US, and India are expected to bear the brunt of the damage, with costs of $10 trillion, $2.5 trillion, and $850 billion, respectively.
The worst affected nations are anticipated to be Trinidad and Tobago with 10.2 percent of GDP and the United Arab Emirates with 11.0% of GDP being accounted for by obesity.
Both direct costs, namely medical expenses, and indirect costs from early mortality and lost output were examined in the report.
The study offers the first estimate of the economic effects of obesity, a major contributor to other non-communicable diseases like cancer, diabetes, and heart disorders, on a country-by-country basis.
According to lead author Rachel Nugent at a briefing on the margins of the UN General Assembly, nearly two in three adults globally are now living with obesity and project there would be three in four adults by 2060.
